Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia

Caroline R.M. Wiggers, Anita M.A.P. Govers, Daphne Lelieveld, David A. Egan, C. Michel Zwaan, Edwin Sonneveld, Paul J. Coffer, Marije Bartels

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences